BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 9570838)

  • 21. [Galactosyl neoglycoalbumin:preparation and studies of its binding with hepatic special receptor].
    Pang Q; Yang L; Zhong Y; Guan C; Zhao Q; Tan T
    Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(4):368-71. PubMed ID: 1814813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of an asialoglycoprotein receptor-targeted magnetic resonance contrast agent to study changes in receptor biology during liver regeneration and endotoxemia in rats.
    Leveille-Webster CR; Rogers J; Arias IM
    Hepatology; 1996 Jun; 23(6):1631-41. PubMed ID: 8675187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation of a retrovirus from multiple sclerosis patients in self-generated Iodixanol gradients.
    Møller-Larsen A; Christensen T
    J Virol Methods; 1998 Aug; 73(2):151-61. PubMed ID: 9766886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tc-99m galactosyl-neoglycoalbumin: in vitro characterization of receptor-mediated binding.
    Vera DR; Krohn KA; Stadalnik RC; Scheibe PO
    J Nucl Med; 1984 Jul; 25(7):779-87. PubMed ID: 6737077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of receptor concentration and forward-binding rate constant via radiopharmacokinetic modeling of technetium-99m-galactosyl-neoglycoalbumin.
    Vera DR; Stadalnik RC; Trudeau WL; Scheibe PO; Krohn KA
    J Nucl Med; 1991 Jun; 32(6):1169-76. PubMed ID: 2045930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of liposome-encapsulated iodixanol in rat liver cells.
    Kjeken R; Kindberg GM; Berg T
    Biochem Pharmacol; 2000 Aug; 60(4):553-9. PubMed ID: 10874130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biosynthetic transport of a major lysosomal membrane glycoprotein, lamp-1: convergence of biosynthetic and endocytic pathways occurs at three distinctive points.
    Akasaki K; Michihara A; Mibuka K; Fujiwara Y; Tsuji H
    Exp Cell Res; 1995 Oct; 220(2):464-73. PubMed ID: 7556456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of (99m)Tc-DMP-NGA as a novel hepatic asialoglycoprotein receptor imaging agent.
    Yang W; Mou T; Zhang X; Wang X
    Appl Radiat Isot; 2010 Jan; 68(1):105-9. PubMed ID: 19815422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The renal Na+/phosphate cotransporter NaPi-IIa is internalized via the receptor-mediated endocytic route in response to parathyroid hormone.
    Bacic D; Lehir M; Biber J; Kaissling B; Murer H; Wagner CA
    Kidney Int; 2006 Feb; 69(3):495-503. PubMed ID: 16514432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased hepatic function in patients with hepatoma or liver metastasis monitored by a hepatocyte specific galactosylated radioligand.
    Virgolini I; Müller C; Klepetko W; Angelberger P; Bergmann H; O'Grady J; Sinzinger H
    Br J Cancer; 1990 Jun; 61(6):937-41. PubMed ID: 2164838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioanalytical methods for iodixanol and their application to studies on metabolism and protein binding.
    Jacobsen PB; Blindheim L; Skotland T
    Acta Radiol Suppl; 1995; 399():61-6. PubMed ID: 8610531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Automatic preparation of radiopharmacokinetic data for in vivo estimation of receptor biochemistry.
    Xu JC; Vera DR; Stadalnik RC
    J Nucl Med; 1996 Nov; 37(11):1896-902. PubMed ID: 8917199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of iodixanol self-generated density gradients to enrich for viable urothelial cells from nonneurogenic and neurogenic bladder tissue.
    Bruce AT; Sangha N; Richmond A; Johnson K; Jones S; Spencer T; Ludlow JW
    Tissue Eng Part C Methods; 2010 Feb; 16(1):33-40. PubMed ID: 19351240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of binding of 125I-iodixanol to high molecular weight substances after incubation with rat liver homogenates.
    Jacobsen PB; Oulie I; Christiansen C; Skotland T
    Acta Radiol; 2001 Jan; 42(1):117-20. PubMed ID: 11167344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation of preformed iodixanol gradients.
    Graham JM
    ScientificWorldJournal; 2002 May; 2():1351-5. PubMed ID: 12805919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro quantification of asialoglycoprotein receptor density from human hepatic microsamples.
    Vera DR; Topcu SJ; Stadalnik RC
    Methods Enzymol; 1994; 247():394-402. PubMed ID: 7898367
    [No Abstract]   [Full Text] [Related]  

  • 37. Stability of the X-ray contrast agent iodixanol=3,3',5,5'-tetrakis(2,3-dihydroxypropylcarbamoyl)- 2,2',4,4',6, 6'-hexaiodo-N,N'-(2-hydroxypropane-1,3-diyl)-diacetanili de towards acid, base, oxygen, heat and light.
    Priebe H; Aukrust A; Bjørsvik HR; Tønseth CP; Wiggen UN
    J Clin Pharm Ther; 1999 Jun; 24(3):227-35. PubMed ID: 10438183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Separation of membrane vesicles and cytosol from yeast, cultured cells, and bacteria in a small volume self-generated gradient in a fixed-angle rotor.
    Graham JM
    ScientificWorldJournal; 2002 Jun; 2():1603-6. PubMed ID: 12806146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seeing through cells: Rapid measurement of intracellular target proteins.
    Larsson PO; Leiva Eriksson N
    Front Bioeng Biotechnol; 2022; 10():996224. PubMed ID: 36263354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteasome Complexes and Their Heterogeneity in Colorectal, Breast and Pancreatic Cancers.
    Zagirova D; Autenried R; Nelson ME; Rezvani K
    J Cancer; 2021; 12(9):2472-2487. PubMed ID: 33854609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.